<Disease><Name>ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)</Name><Synonym>ANTITRYPSIN; ALPHA(1)-ANTITRYPSIN DEFICIENCY; PROTEASE INHIBITOR 1</Synonym><OMIM><Number>613490</Number><URL>http://omim.org/entry/613490</URL></OMIM><Orphanet><Number>60</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=60</URL></Orphanet><Protein><Number>alpha-1-antitrypsin</Number><URL>http://www.uniprot.org/uniprot/P01009</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>14q32.13</Gene><ICD>E88.0</ICD><Summary>rare (1-5:10000) ;autosomal recessive;mutation in the SERPINA1 gene ; &gt; 70 genetic variants (PI types) therapy: risks of smoking ! aggresive treatment of pulmonary infections enzyme replacement (pooled human blood or recombinant AAT) liver transplantation</Summary><Symptoms><symtomp><id>2257</id><symptom>cholestasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3178</id><symptom>dyspnea</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>3162</id><symptom>emphysema</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1988</id><symptom>gastrointestinal hemorrhage (bleeding)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1873</id><symptom>jaundice</symptom><category>LABORATORY FINDINGS | SKIN</category></symtomp><symtomp><id>2487</id><symptom>liver carcinoma</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2380</id><symptom>liver failure</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2210</id><symptom>pancreatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2273</id><symptom>pneumonia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>3176</id><symptom>portal hypertension</symptom><category>CARDIOVASCULAR SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1151</id><name>alpha-1-Antitrypsin</name><specimen>serum</specimen><value>decreased</value><min>150.00</min><max>350.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>decreased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7953</id><title>Detection of alpha-1 antitrypsin deficiency: the past, present and future</title><author>Brantly M,</author><journal>Orphanet J Rare Dis</journal><year>2020</year><book /><volume>15</volume><number>1</number><pages>96</pages><co_aut>et al.</co_aut></literature><literature><id>4081</id><title>State-of-the-art testing for alpha-1 antitrypsin deficiency</title><author>Kueppers F,</author><journal>Allergy Asthma Proc</journal><year>2017</year><book /><volume>38</volume><number>2</number><pages>108-114</pages><co_aut>Sanders C.</co_aut></literature><literature><id>3592</id><title>Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications</title><author>Zuo L,</author><journal>Gene</journal><year>2016</year><book /><volume>589</volume><number>2</number><pages>118-122</pages><co_aut>et al.</co_aut></literature><literature><id>3595</id><title>Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis</title><author>Greulich T,</author><journal>Ther Adv Respir Dis</journal><year>2016</year><book /><volume>10</volume><number>1</number><pages>72-84</pages><co_aut>Vogelmeier CF</co_aut></literature><literature><id>3283</id><title>Adult liver disorders caused by inborn errors of metabolism: review and update</title><author>Chanprasert S,</author><journal>Mol Genet Metab</journal><year>2015</year><book /><volume>114</volume><number>1</number><pages>1-10</pages><co_aut>Scaglia F</co_aut></literature><literature><id>3593</id><title>Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Dise</title><author>Stoller JK,</author><journal>Ann Am Thorac Soc</journal><year>2015</year><book /><volume>12</volume><number>2</number><pages>1796-1804</pages><co_aut>et al.</co_aut></literature><literature><id>3594</id><title>Neutrophilic Panniculitis Associated with Alpha-1 Antitrypsin Deficiency: an Update</title><author>Blanco I,</author><journal>Br J Dermatol</journal><year>2015</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3596</id><title>Diagnosing alpha1-antitrypsin deficiency: how to improve the current algorithm</title><author>McElvaney NG</author><journal>Eur Respir Rev</journal><year>2015</year><book /><volume>24</volume><number>135</number><pages>52-57</pages><co_aut /></literature><literature><id>3597</id><title>Long-term experience in the treatment of alpha1-antitrypsin deficiency: 25&#8197;years of augmentation therapy</title><author>Teschler H</author><journal>Eur Respir Rev</journal><year>2015</year><book /><volume>24</volume><number>135</number><pages>46-51</pages><co_aut /></literature><literature><id>3599</id><title>Current status of gene therapy for alpha-1 antitrypsin deficiency</title><author>Loring HS,</author><journal>Expert Opin Biol Ther</journal><year>2015</year><book /><volume>15</volume><number>3</number><pages>329-336</pages><co_aut>Flotte TR</co_aut></literature><literature><id>3598</id><title>Molecular pathogenesis of alpha-1-antitrypsin deficiency</title><author>Duvoix A,</author><journal>Rev Mal Respir</journal><year>2014</year><book /><volume>31</volume><number>10</number><pages>992-1002</pages><co_aut>Roussel BD, Lomas DA</co_aut></literature><literature><id>3600</id><title>Diagnosis of alpha-1 antitrypsin deficiency: modalities, indications and diagnosis strategy</title><author>Balduyck M,</author><journal>Rev Mal Respir</journal><year>2014</year><book /><volume>31</volume><number>8</number><pages>729-745</pages><co_aut>et al.</co_aut></literature><literature><id>1391</id><title>Inhibiting polymerisation: new therapeutic strategies for Z {alpha}1-antitrypsin related emphysema</title><author>Parfrey H</author><journal>Am J Respir Cell Mol Biol</journal><year>2004</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>1392</id><title>Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies</title><author>Crowther DC</author><journal>Eur J Hum Genet</journal><year>2004</year><book /><volume>12</volume><number>3</number><pages>167-172</pages><co_aut>et al.</co_aut></literature><literature><id>1393</id><title>Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vecto</title><author>Flotte TR</author><journal>Hum Gene Ther</journal><year>2004</year><book /><volume>15</volume><number>1</number><pages>93-128</pages><co_aut>et al.</co_aut></literature><literature><id>1390</id><title>Alpha(1)-antitrypsin deficiency, liver disease and emphysema</title><author>Parfrey H</author><journal>Int J Biochem Cell Biol</journal><year>2003</year><book /><volume>35</volume><number>7</number><pages>1009-1014</pages><co_aut>et al.</co_aut></literature><literature><id>1611</id><title>Panniculitis secondary to extravasation of clarithromycin in a patient with alpha 1-antitrypsin deficiency (phenotype PiZ)</title><author>Parr DG</author><journal>Br J Dermatol</journal><year>2003</year><book /><volume>149</volume><number>2</number><pages>410-413</pages><co_aut>et al.</co_aut></literature><literature><id>1612</id><title>Importance of serum interleukin-6 as a mediator of systemic inflammation in patients with alpha-1 antitrypsin deficiency</title><author>Vila S</author><journal>Arch Bronconeumol</journal><year>2002</year><book /><volume>38</volume><number>6</number><pages>263-266</pages><co_aut>et al.</co_aut></literature><literature><id>1613</id><title>Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-</title><author>Gottlieb DJ</author><journal>Am J Respir Crit Care Med</journal><year>2000</year><book /><volume>162</volume><number>6</number><pages>2069</pages><co_aut>et al.</co_aut></literature><literature><id>1091</id><title>Ribozyme-mediated specific gene replacement of the alpha1-antitrypsin gene in human hepatoma cells</title><author>Ozaki I</author><journal>J Hepatol</journal><year>1999</year><book /><volume>31</volume><number>0</number><pages>53-60</pages><co_aut>et al.</co_aut></literature><literature><id>549</id><title>Alpha-1-Antitrypsin deficiency</title><author>Feist DJF</author><journal>in Fernandes J, Saudubray JM, Tada K (eds): Inborn metabolic diseases, diagnosis and treatment; 2nd edition; Berlin, Springer Verlag</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>361-363</pages><co_aut /></literature><literature><id>547</id><title>alpha1-Antitrypsin deficiency</title><author>Wilson Cox D</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>3</volume><number>138</number><pages>4125</pages><co_aut /></literature><literature><id>548</id><title>The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency</title><author>Laurell CB</author><journal>Scand J Clin Lab Invest</journal><year>1963</year><book /><volume>15</volume><number>0</number><pages>132-140</pages><co_aut>Eriksson S</co_aut></literature></Literatures></Disease>